title: Intravenous tissue plasminogen activator thrombolysis in patients with diabetes mellitus and previous stroke.
authors.forename: Ayoze N
authors.initials: AN
authors.lastname: Gonzalez-Hernandez
authors.forename: Oscar
authors.initials: O
authors.lastname: Fabre-Pi
authors.forename: Juan C
authors.initials: JC
authors.lastname: Lopez-Fernandez
authors.forename: Santiago
authors.initials: S
authors.lastname: Diaz-Nicolas
mesh_terms: D015984:Causality; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control; D000075202:Contraindications; D048909:Diabetes Complications / Q000503:physiopathology*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects; D020767:Intracranial Thrombosis / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D008487:Medical History Taking; D018579:Patient Selection; D018570:Risk Assessment; D020521:Stroke / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator